Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J. Courties A, et al. Among authors: terrier b. Sci Rep. 2021 Jun 4;11(1):11886. doi: 10.1038/s41598-021-91417-7. Sci Rep. 2021. PMID: 34088975 Free PMC article.
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
Terrier B, Saadoun D, Sène D, Sellam J, Pérard L, Coppéré B, Karras A, Blanc F, Buchler M, Plaisier E, Ghillani P, Rosenzwajg M, Cacoub P. Terrier B, et al. Arthritis Rheum. 2009 Aug;60(8):2531-40. doi: 10.1002/art.24703. Arthritis Rheum. 2009. PMID: 19644879 Free article. Clinical Trial.
Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases.
Droz N, Gilardin L, Cacoub P, Berenbaum F, Wendling D, Godeau B, Piette AM, Dernis E, Ebbo M, Fautrel B, Le Guenno G, Mekinian A, Bernard-Chabert B, Costedoat-Chalumeau N, Descloux E, Michot JM, Radenne S, Rigolet A, Rivière S, Yvin JL, Thibault V, Thabut D, Pol S, Guillevin L, Mouthon L, Terrier B. Droz N, et al. Among authors: terrier b. Arthritis Care Res (Hoboken). 2013 Sep;65(9):1504-14. doi: 10.1002/acr.21990. Arthritis Care Res (Hoboken). 2013. PMID: 23436730 Free article. Review.
mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.
Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group. Hadjadj J, et al. Among authors: terrier b. Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017. Rheumatology (Oxford). 2018. PMID: 29506143
Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.
Dollat M, Chaigne B, Cormier G, Costedoat-Chalumeau N, Lifermann F, Deroux A, Berthoux E, Dernis E, Sené T, Blaison G, Lambotte O, Terrier B, Sellam J, De Saint-Martin L, Chiche L, Dupin N, Mouthon L. Dollat M, et al. Among authors: terrier b. BMC Infect Dis. 2018 Jul 4;18(1):302. doi: 10.1186/s12879-018-3227-1. BMC Infect Dis. 2018. PMID: 29973155 Free PMC article.
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N. Mahévas M, et al. Among authors: terrier b. BMJ. 2020 May 14;369:m1844. doi: 10.1136/bmj.m1844. BMJ. 2020. PMID: 32409486 Free PMC article.
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, Khider L, Hadjadj J, Goudot G, Debuc B, Juvin P, Hauw-Berlemont C, Augy JL, Peron N, Messas E, Planquette B, Sanchez O, Charbit B, Gaussem P, Duffy D, Terrier B, Mirault T, Diehl JL. Smadja DM, et al. Among authors: terrier b. Angiogenesis. 2020 Nov;23(4):611-620. doi: 10.1007/s10456-020-09730-0. Epub 2020 May 27. Angiogenesis. 2020. PMID: 32458111 Free PMC article.
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B. Hadjadj J, et al. Among authors: terrier b. Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13. Science. 2020. PMID: 32661059 Free PMC article.
463 results